VKTX – Viking Therapeutics, Inc.
Float Short %
23.24
Margin Of Safety %
Put/Call OI Ratio
0.22
EPS Next Q Diff
0.4
EPS Last/This Y
-0.92
EPS This/Next Y
-0.46
Price
31.04
Target Price
92.94
Analyst Recom
1.11
Performance Q
-17.82
Upside
-233.2%
Beta
0.76
Ticker: VKTX
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-01-23 | VKTX | 32.22 | 0.26 | 0.46 | 173277 |
| 2026-01-26 | VKTX | 31.74 | 0.27 | 0.30 | 156503 |
| 2026-01-27 | VKTX | 31.45 | 0.27 | 0.10 | 159556 |
| 2026-01-28 | VKTX | 30.53 | 0.26 | 0.21 | 161801 |
| 2026-01-29 | VKTX | 30.25 | 0.26 | 0.19 | 166080 |
| 2026-01-30 | VKTX | 29.08 | 0.26 | 0.43 | 167263 |
| 2026-02-02 | VKTX | 29.92 | 0.26 | 0.14 | 156374 |
| 2026-02-03 | VKTX | 29.45 | 0.26 | 0.13 | 163333 |
| 2026-02-04 | VKTX | 29.54 | 0.26 | 0.12 | 168914 |
| 2026-02-05 | VKTX | 26.28 | 0.25 | 0.26 | 175400 |
| 2026-02-06 | VKTX | 28.18 | 0.24 | 0.20 | 178083 |
| 2026-02-09 | VKTX | 29.31 | 0.24 | 0.11 | 166568 |
| 2026-02-10 | VKTX | 28.74 | 0.24 | 0.28 | 170498 |
| 2026-02-11 | VKTX | 28.56 | 0.24 | 0.17 | 171677 |
| 2026-02-12 | VKTX | 30.52 | 0.24 | 0.29 | 184455 |
| 2026-02-13 | VKTX | 29.03 | 0.24 | 0.36 | 188487 |
| 2026-02-17 | VKTX | 30.44 | 0.23 | 0.24 | 176210 |
| 2026-02-18 | VKTX | 30.07 | 0.23 | 0.53 | 184977 |
| 2026-02-19 | VKTX | 31.12 | 0.23 | 0.10 | 186045 |
| 2026-02-20 | VKTX | 31.03 | 0.22 | 0.23 | 186789 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-01-23 | VKTX | 32.22 | -181.2 | - | -2.61 |
| 2026-01-26 | VKTX | 31.76 | -181.2 | - | -2.61 |
| 2026-01-27 | VKTX | 31.40 | -181.2 | - | -2.61 |
| 2026-01-28 | VKTX | 30.42 | -181.2 | - | -2.61 |
| 2026-01-29 | VKTX | 30.27 | -181.2 | - | -2.61 |
| 2026-01-30 | VKTX | 29.05 | -181.2 | - | -2.61 |
| 2026-02-02 | VKTX | 29.92 | -181.2 | - | -2.61 |
| 2026-02-03 | VKTX | 29.44 | -181.2 | - | -2.61 |
| 2026-02-04 | VKTX | 29.56 | -181.2 | - | -2.61 |
| 2026-02-05 | VKTX | 26.29 | -181.2 | - | -2.61 |
| 2026-02-06 | VKTX | 28.43 | -181.2 | - | -2.61 |
| 2026-02-09 | VKTX | 29.31 | -181.2 | - | -2.61 |
| 2026-02-10 | VKTX | 28.73 | -181.7 | - | -2.61 |
| 2026-02-11 | VKTX | 28.56 | -181.7 | - | -2.61 |
| 2026-02-12 | VKTX | 30.52 | -181.7 | - | -2.61 |
| 2026-02-13 | VKTX | 29.23 | -142.9 | - | -4.28 |
| 2026-02-17 | VKTX | 30.44 | -141.1 | 20.1 | -4.22 |
| 2026-02-18 | VKTX | 30.13 | -133.4 | 46.9 | -4.11 |
| 2026-02-19 | VKTX | 31.10 | -133.4 | - | -4.11 |
| 2026-02-20 | VKTX | 31.04 | -133.4 | - | -4.11 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-01-23 | VKTX | -12.49 | -3.39 | 22.19 |
| 2026-01-26 | VKTX | -12.49 | -3.31 | 22.19 |
| 2026-01-27 | VKTX | -12.49 | -3.31 | 22.19 |
| 2026-01-28 | VKTX | -12.49 | -3.31 | 22.91 |
| 2026-01-29 | VKTX | -12.49 | -3.31 | 22.91 |
| 2026-01-30 | VKTX | -12.49 | -3.31 | 22.91 |
| 2026-02-02 | VKTX | -12.49 | -3.47 | 22.91 |
| 2026-02-03 | VKTX | -12.49 | -3.47 | 22.91 |
| 2026-02-04 | VKTX | -12.49 | -3.47 | 22.91 |
| 2026-02-05 | VKTX | -12.49 | -3.47 | 22.91 |
| 2026-02-06 | VKTX | -12.49 | -3.47 | 22.91 |
| 2026-02-09 | VKTX | -12.49 | -3.44 | 22.91 |
| 2026-02-10 | VKTX | -12.49 | -3.44 | 22.91 |
| 2026-02-11 | VKTX | -12.49 | -3.44 | 23.76 |
| 2026-02-12 | VKTX | -12.49 | -3.44 | 23.76 |
| 2026-02-13 | VKTX | -12.49 | -3.44 | 23.76 |
| 2026-02-17 | VKTX | -12.26 | -2.05 | 23.24 |
| 2026-02-18 | VKTX | -12.25 | -2.05 | 23.24 |
| 2026-02-19 | VKTX | -12.25 | -2.05 | 23.24 |
| 2026-02-20 | VKTX | -12.25 | -2.05 | 23.24 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-1.38
Avg. EPS Est. Current Quarter
-0.96
Avg. EPS Est. Next Quarter
-0.98
Insider Transactions
-12.25
Institutional Transactions
-2.05
Beta
0.76
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
9
Growth Score
18
Sentiment Score
48
Actual DrawDown %
68.8
Max Drawdown 5-Year %
-78.9
Target Price
92.94
P/E
Forward P/E
PEG
P/S
P/B
5.57
P/Free Cash Flow
EPS
-3.18
Average EPS Est. Cur. Y
-4.11
EPS Next Y. (Est.)
-4.57
Target Price Estimates Raised
Target Price Estimates Lowered
1
Profit Margin
Relative Volume
0.59
Return on Equity vs Sector %
-85.3
Return on Equity vs Industry %
-67.8
EPS 1 7Days Diff
-0.4
EPS 1 30Days Diff
-0.4
EBIT Estimation
Viking Therapeutics, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 53
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. Its lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. The company develops VK5211, an orally available non-steroidal selective androgen receptor modulator that is in Phase II clinical trials for the treatment of patients recovering from non-elective hip fracture surgery; VK0612, which is in Phase II clinical trials for metabolic disorders and anemia; VK2735, a novel dual agonist of the glucagon-like peptide 1, which is in Phase 1 SAD/MAD clinical trial, and VK0214, an orally available tissue and receptor-subtype selective agonist of the TRß for X-linked adrenoleukodystrophy. The company was incorporated in 2012 and is headquartered in San Diego, California.
stock quote shares VKTX – Viking Therapeutics, Inc. Stock Price stock today
news today VKTX – Viking Therapeutics, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch VKTX – Viking Therapeutics, Inc. yahoo finance google finance
stock history VKTX – Viking Therapeutics, Inc. invest stock market
stock prices VKTX premarket after hours
ticker VKTX fair value insiders trading